What Are Subcutaneous Fluids and Why Are They Used?

Subcutaneous fluids are liquids delivered just beneath the skin, into the layer of fat and connective tissue that sits between the skin’s surface and the muscle below. The technique, formally called hypodermoclysis, has been used for over a century, fell out of favor for decades, and has been quietly making a comeback in specific medical settings where getting a needle into a vein is difficult, impractical, or unnecessary. It is used in elderly patients, young children, people receiving palliative care, and even in cats with kidney disease. The method turns out to be surprisingly effective for mild to moderate dehydration, and in many cases it is safer and cheaper than intravenous (IV) delivery.

How Subcutaneous Fluid Delivery Works

When fluid is injected beneath the skin, it pools in the subcutaneous tissue and forms a visible lump. Over the next several minutes to hours, the body absorbs that fluid into the bloodstream through tiny blood vessels and lymphatic channels in the surrounding tissue. The process is slower than an IV drip, which delivers fluid directly into the circulation, but it still gets the job done for situations where rapid, high-volume infusion is not critical.

The subcutaneous space is made up of a mesh-like network of connective tissue fibers, fat cells, and a gel-like ground substance that contains hyaluronic acid. That gel acts as a kind of cement between cells, which limits how quickly fluid can spread and be absorbed. This is why subcutaneous infusions work best at moderate volumes and flow rates. International consensus guidelines recommend limiting infusion to about one liter per day at each site, and medication infusion rates of no more than about 5 milliliters per hour unless the manufacturer specifies otherwise.¹

To speed things up, clinicians sometimes pre-treat the injection site with an enzyme called hyaluronidase. This enzyme breaks down hyaluronic acid in the connective tissue, loosening up the subcutaneous space so fluid can spread over a larger area and be absorbed faster.² With hyaluronidase on board, flow rates can climb dramatically, reaching several hundred milliliters per hour in some protocols. A modern recombinant version of this enzyme is now widely available and has expanded the range of what subcutaneous delivery can handle.

Why Use the Subcutaneous Route Instead of an IV

The most common reason is simple: sometimes you cannot get an IV line in. Veins can be fragile, collapsed, or scarred from repeated access. This is especially true in elderly patients who are dehydrated, in very young children whose veins are tiny, and in people who have undergone extensive chemotherapy. In one case report, a seven-week-old infant with dehydration from a kidney infection had multiple failed IV attempts, even under general anesthesia. Subcutaneous fluids were used as a bridge, and once the baby was better hydrated, the veins plumped up enough for an IV to be placed successfully.³

Beyond vein trouble, subcutaneous fluids offer practical advantages that make them appealing even when IV access is theoretically possible. The insertion is easier and less painful than placing an IV catheter. The infusion site requires less monitoring, there is no risk of air embolism, and the chance of serious bloodstream infection is much lower. A review of the available evidence found that subcutaneous infusion has similar effectiveness and safety to the IV route, with the added benefits of easier setup, lower cost, and fewer severe complications, particularly infections.⁴

For patients receiving care at home or in long-term care facilities, those practical advantages matter a lot. An IV line needs trained staff to place and monitor, and it ties the patient to a pole or pump. Subcutaneous lines can be placed by nurses with basic training, or even by family caregivers after instruction. Patients can move around more freely, and the setup can be managed in settings where round-the-clock nursing is not available.

Where Subcutaneous Fluids Are Used Most

Three populations account for the bulk of subcutaneous fluid use in humans: older adults with mild to moderate dehydration, children with difficult IV access, and patients receiving palliative or end-of-life care.

In elderly patients, dehydration is common and frequently underdiagnosed. It can result from reduced thirst sensation, medication side effects, or difficulty swallowing enough fluid. Hypodermoclysis has been recognized as a safe and effective method for rehydrating older adults who are mildly to moderately dehydrated, and it is also used for delivering pain medications such as opioids in patients with cancer.⁵ Studies on opioid delivery through the subcutaneous route have found that drug levels in the blood are comparable to those achieved with IV administration, which means patients can receive effective pain control without a more invasive line.

In children, the subcutaneous route has been studied as an alternative when IV access fails or is too distressing. A clinical trial in mildly to moderately dehydrated children found that subcutaneous hydration assisted by recombinant hyaluronidase was a reasonable treatment option, particularly for kids with difficult veins.⁶ A cost-effectiveness analysis of the same approach found it was economically favorable in children under three, largely because gaining subcutaneous access was faster and easier than fighting for IV access, which shortened the time families spent in the emergency department.⁷

In palliative care, subcutaneous delivery is valued for its gentleness. Patients at the end of life often have poor veins, limited mobility, and fragile skin. Starting and maintaining an IV can be uncomfortable and distressing, and the risk of complications like phlebitis or infection can outweigh the benefit. Subcutaneous infusions of fluids and medications offer a less invasive way to manage symptoms, keep patients comfortable, and avoid unnecessary hospital transfers.

Safety Profile and Common Side Effects

The side effects of subcutaneous fluids are mostly local and mild. The injection site can become swollen, red, or tender while fluid is being absorbed, and some patients experience mild discomfort during the infusion. A systematic review of systematic reviews on the topic found that subcutaneous hydration in both children and elderly patients was safe and equivalent to IV hydration in terms of local reactions and systemic events. In several measures, the subcutaneous route actually came out ahead: infection rates were higher with IV lines, catheter dislodgement was more common with IV access in elderly patients, and device-related agitation was lower with subcutaneous infusion.⁸

Serious complications are rare. Cellulitis (a skin infection around the insertion site) has been reported but occurs less often than with IV catheters. Fluid overload is theoretically possible but unlikely at the volumes typically used. The subcutaneous route is not appropriate for rapid, large-volume resuscitation, so it is avoided in cases of severe dehydration, shock, or acute blood loss where fast intravascular volume replacement is critical.

There are also some solutions that should not be given subcutaneously. Hypertonic solutions, solutions containing potassium chloride at high concentrations, and blood products are not suitable for the subcutaneous route. The fluids most commonly used are normal saline and lactated Ringer’s solution. In a study comparing the two, volunteers who received lactated Ringer’s reported less pain and fewer injection-site reactions than those who received normal saline, and all participants preferred the lactated Ringer’s infusion.⁹

The Practical Setup

If you have never seen a subcutaneous infusion, the procedure is straightforward. A small, soft cannula (typically a short, fine-gauge needle or plastic catheter, around 24 to 27 gauge) is inserted into the subcutaneous tissue at a common site such as the abdomen, thigh, or upper arm. The consensus guidelines recommend choosing a site with intact skin and at least about one to two and a half centimeters of subcutaneous tissue thickness. In slim patients, the clinician lifts a fold of skin to avoid going too deep into muscle.¹

Once the needle is in place, fluid is delivered by gravity drip or a small pump. For hydration, the infusion can run over several hours, and patients can go about their day with minimal disruption. If hyaluronidase is being used, it is typically injected through the same site before the fluid infusion begins. The site is rotated regularly to prevent skin irritation, and multiple sites can be used simultaneously if larger volumes are needed.

The simplicity of the setup is one of its biggest selling points. Unlike IV access, which may require ultrasound guidance, tourniquet use, and practiced technique to thread a catheter into a vein, subcutaneous access can be achieved on the first attempt in most patients. For caregivers at home, this means less anxiety and fewer failed attempts.

Subcutaneous Delivery Beyond Simple Hydration

The subcutaneous route is not just for saline and water. It has become an important delivery method for a growing list of medications, including insulin (which has been given subcutaneously for a century), certain biologic drugs, immunoglobulins, and pain medications. For many of these drugs, subcutaneous injection produces blood levels that are clinically comparable to IV or intramuscular delivery. Research on glucagon, for instance, found that while IV injection produced the fastest peak in blood levels, subcutaneous and intramuscular injections were equally effective at raising blood sugar in emergencies.¹⁰

The absorption of larger molecules like monoclonal antibodies through subcutaneous tissue is more variable. Bioavailability for these drugs can range from about 50 percent to 100 percent, depending on the specific drug’s properties.¹¹ This variability is one reason pharmaceutical companies invest heavily in formulation science to optimize subcutaneous versions of drugs originally designed for IV infusion.

One high-profile example involves lecanemab, a drug used to treat early Alzheimer’s disease that was originally given intravenously. A cost comparison model estimated that switching to subcutaneous delivery could save roughly $18,000 to $20,000 per patient per year, primarily from lower treatment costs, shorter administration times, and reduced burden on quality of life. At the population level, with projected uptake rates, those savings could add up to billions of dollars over four years.¹² For patients and families, the appeal is not just financial: subcutaneous injections can be done at home, eliminating hours-long trips to infusion centers.

Subcutaneous Fluids in Veterinary Medicine

If you have a cat with chronic kidney disease, there is a good chance your veterinarian has discussed subcutaneous fluids with you. Cats with failing kidneys lose the ability to concentrate their urine and become chronically dehydrated. Subcutaneous fluids given at home, usually under the loose skin between the shoulder blades, are one of the most common long-term treatments prescribed for these animals.

A survey of cat owners who administered subcutaneous fluids at home found that most reported positive experiences with learning and performing the technique. Owners noted that tailoring the protocol to their individual cat’s preferences, such as warming the fluid, choosing a calm environment, or adjusting the timing, improved the cat’s tolerance over time.¹³ For many cats, the procedure becomes routine, something managed in a few minutes on the kitchen counter rather than requiring a stressful trip to the clinic.

The veterinary application is a useful illustration of the technique’s strengths. It works well for chronic, moderate-volume hydration. It can be done by non-professionals after proper training. And the subcutaneous tissue in cats (and humans) is remarkably forgiving of small imperfections in technique. The needle does not need to be in a precise blood vessel; it just needs to be in the right tissue layer.

What Patients and Families Think

Patient perception of subcutaneous fluids is mixed and depends heavily on context. The systematic review evidence shows that patients and caregivers tend to prefer the subcutaneous route when it is compared directly to IV access in terms of ease and comfort. Device-related agitation is lower, placement is easier, and satisfaction scores for both patients and caregivers favor subcutaneous delivery.⁸

However, a study exploring perceptions among patients and their relatives found that many considered the subcutaneous route less effective than IV delivery, and did not find it less bothersome.¹⁴ This perception gap is worth noting. People associate IV drips with “real” medical treatment: visible, fast, and technologically sophisticated. Subcutaneous fluids, by comparison, look unimpressive. A small needle under the skin, a slow drip, a temporary lump of fluid. It does not look like much is happening, even when it is working just as well for the level of dehydration being treated. Clinicians who use hypodermoclysis regularly often say that educating patients and families about how it works, and setting realistic expectations about the visible lump and gradual absorption, goes a long way toward improving acceptance.

Limitations and When Not to Use Them

Subcutaneous fluids are not a universal replacement for IV access. They have clear boundaries. You should not rely on them for severe dehydration, hemorrhagic shock, or any situation requiring rapid high-volume resuscitation. The absorption rate, even with hyaluronidase, cannot match the speed of direct IV infusion when time is critical. A systematic review of alternative rehydration methods noted that evidence for subcutaneous rehydration remains limited compared to other routes and called for more research before it could be broadly endorsed for rehydration in resource-limited settings.¹⁵

Certain patient populations also need extra caution. People with severe clotting disorders, severe peripheral edema, or skin conditions at the intended insertion sites may not be good candidates. And while the risk of infection is lower than with IV catheters, it is not zero; sterile technique still matters.

There are also pharmacological limits. Not every drug is appropriate for subcutaneous delivery. Solutions need to be isotonic or close to it, and the volume per site is capped. Drugs that are highly irritating to tissue, that require very precise dosing with immediate systemic effect, or that need to reach the bloodstream in seconds rather than minutes generally still need an IV.

The Expanding Role of Subcutaneous Delivery in Drug Development

Pharmaceutical companies are increasingly developing subcutaneous formulations of drugs that were originally IV-only. The appeal is obvious from every angle: patients avoid infusion centers, healthcare systems save money on administration costs and nursing time, and drug makers can differentiate their product. Subcutaneous versions of monoclonal antibodies for cancer, autoimmune disease, and neurological conditions are in various stages of development and approval.

Hyaluronidase has become a key enabling technology in this space. By co-formulating drugs with the enzyme, companies can push larger volumes of medication through the subcutaneous route than would otherwise be feasible.² Several commercially available biologic drugs already use this approach, combining the active drug with recombinant hyaluronidase so that a treatment that would have required a multi-hour IV infusion can instead be given as a subcutaneous injection in minutes. The lecanemab example in Alzheimer’s disease is just one instance of a broader trend that is reshaping how many chronic-disease treatments are delivered.

For patients, this shift often means the difference between spending half a day at a clinic every few weeks and doing a quick injection at home. The clinical efficacy does not change, but the quality-of-life improvement can be substantial. As formulation science continues to advance, it is likely that more drugs will make the transition from IV to subcutaneous delivery, further expanding the role of a technique that was once considered outdated and limited.